IBD 50 Shows Lots Of Stocks Poised To Break Out – Investor's Business Daily
IBD 50 Shows Lots Of Stocks Poised To Break OutInvestor’s Business DailyLook at Alexion Pharmaceuticals (ALXN), whose drugs target cancer, autoimmune disorders and transplant rejection. The stock has shaped a tight, low-volume flat base. The buy point …